Spire Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Spire Wealth Management's BIIB Position: Q2 2026 in Review
Spire Wealth Management reduced its Biogen (BIIB) stake by 36% in Q2 2026, selling an estimated $6.7K and leaving 61 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.
Spire Wealth Management first reported a position in BIIB in Q1 2021 and has held it in 22 quarters since. The position peaked at $707K in Q1 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Spire Wealth Management held 61 shares of Biogen worth $13.2K as of Q2 2026.
- Spire Wealth Management sold 35 Biogen shares in Q2 2026, an estimated $6.7K.
- Biogen made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1563 holding.
- Spire Wealth Management first reported a position in Biogen in Q1 2021 and has held it in 22 quarters since.
- Spire Wealth Management's Biogen position peaked at $707K in Q1 2021.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.